Novel SARS-CoV-2 Variant Derived from Clade 19B, France.

COVID-19 France HMN.19B variant Henri Mondor variant SARS-CoV-2 clade coronavirus disease respiratory infections severe acute respiratory syndrome coronavirus 2 viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 22 6 2021
Statut: ppublish

Résumé

We report a novel severe acute respiratory syndrome coronavirus 2 variant derived from clade 19B (HMN.19B variant or Henri Mondor variant). This variant is characterized by the presence of 18 amino acid substitutions, including 7-8 substitutions in the spike protein and 2 deletions. These variants actively circulate in different regions of France.

Identifiants

pubmed: 33900195
doi: 10.3201/eid2705.210324
pmc: PMC8084519
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1540-1543

Références

Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Elife. 2020 Oct 28;9:
pubmed: 33112236
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH